摘要
目的:探讨早期口服美托洛尔减少急性心肌梗死室性或室上性心律失常的作用。方法:将96例急性心肌梗死随机分为治疗组48例和对照组48例,治疗组在常规治疗基础上口服美托洛尔25～50mg/次,2次/d;对照组仅予常规治疗。结果:在治疗后的第3个月和第6个月时,美托洛尔组发生室性、室上性心律失常及死于心律失常的患者明显减少,与对照组相比差异具有统计学意义(P<0.05)。结论:急性心肌梗死早期口服美托洛尔能减少室性和室上性心律失常的发生。
Objective：To affirmif Metopmlol call reduce venft ricular arrhythmia and supraventrieul arrhythmia given early in acute myocardial infarction（AMI）. Methods ：96 patients with AMI were randomly divided into treatment group and control group, the treatment group was given Metopmlol 25 ~ 50rag, bid additionally, the control group was given conventional treatment. Results：3 and 6 months later, events of vemrieular arrhythmla, supravent- ricular arrhythmia, decease of arrhythmla in treatment group were less than those in control group （P 〈 0.05 ）. Conclusion： Given early in AMI, metopmlol has a powerful ant iarr hythm ic effect in supples sing ventricular arrhythmias as w ell as supravent rieular arrhydun ias.
出处
《中国民康医学》
2011年第18期2225-2225,2234,共2页
Medical Journal of Chinese People’s Health
关键词
心肌梗死
美托洛尔
心律失常
Miocardial infarction
Metoprolol
Arrhythmia
